RxDoctor Payments Data

Luis Garcia, DPM

Podiatrist · Wilmington, DENPI 1306834585

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Stryker at 33.4% of the total. Reporting peaked in 2022 at $468 and has fallen 77.1% since, to $107 in 2025. That places this record below the midpoint for podiatrist clinicians in DE, where the typical reported total is $1,099.

$1,057in general payments, 2019–2025

Across 15 payments — averaging $70.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$353
  • Integra Lifesciences Corporation$279
  • Smith+Nephew$187
  • Cardiovascular Systems Inc.$128
  • Zimmer Biomet$48
  • Johnson & Johnson$29
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$1,057100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,057 in reported general payments places this provider in the 45th percentile of 37 podiatrist providers in Delaware.

See all podiatrist providers in Delaware

Medicare billing

Part B allowed, 2024
$220,334
Medicare patients
643
Services billed
2,832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole43$1,117
Meloxicam100$912
Dicloxacillin Sodium64$730
Ammonium Lactate19$558
Levofloxacin42$452
Methylprednisolone58$405
Terbinafine Hcl19$403
Ciprofloxacin Hcl28$251
Doxycycline Hyclate48$247
Gabapentin14$201
Acetaminophen-CodeineAcetaminophen With Codeine28$118

Paid to pharmacies, not to this prescriber.

Other podiatrist in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →